Blood Trace Element Status in Multiple Sclerosis: a Systematic Review and Meta-analysis
Blood Trace Element Status in Multiple Sclerosis: a Systematic Review and Meta-analysis
Nirooei et al., 2022 | Biol Trace Elem Res | Meta Analysis
Citation
Nirooei Elahe, Kashani Seyyed Mohammad Amin, ... Akbari Hamed. Blood Trace Element Status in Multiple Sclerosis: a Systematic Review and Meta-analysis. Biol Trace Elem Res. 2022-Jan;200(1):13-26. doi:10.1007/s12011-021-02621-5
Abstract
The aim of this meta-analysis was to investigate whether the blood concentrations of patients with multiple sclerosis (MS) are associated with those of the healthy control group in terms of trace elements including zinc (Zn), iron (Fe), manganese (Mn), magnesium (Mg), selenium (Se), and copper (Cu). A comprehensive search was performed in online databases including PubMed, Scopus, Embase, and Web of Science for studies, which have addressed trace elements in MS up to July 23, 2020. The chi-square test and I2 statistic were utilized to evaluate inter-study heterogeneity across the included studies. Weighted mean differences (WMDs) and corresponding 95% CI were considered as a pooled effect size (ES). Twenty-seven articles (or 32 studies) with a total sample comprised of 2895 participants (MS patients (n = 1567) and controls (n = 1328)) were included. Pooled results using random-effects model indicated that the levels of Zn (WMD = - 7.83 mcg/dl, 95% CI = - 12.78 to - 2.87, Z = 3.09, P = 0.002), and Fe (WMD = - 13.66 mcg/dl, 95% CI = - 23.13 to - 4.19, Z = 2.83, P = 0.005) were significantly lower in MS patients than in controls. However, it was found that levels of Mn (WMD = 0.03 mcg/dl, 95% CI = 0.01 to 0.04, Z = 2.89, P = 0.004) were significantly higher in MS patients. Yet, no significant differences were observed in the levels of Mg, Se, and Cu between both groups. This meta-analysis revealed that the circulating levels of Zn and Fe were significantly lower in MS patients and that Mn level was significantly higher than those in the control group. However, it was found that there was no significant difference between MS patients and controls with regard to levels of Mg, Se, and Cu.
Key Findings
However, it was found that there was no significant difference between MS patients and controls with regard to levels of Mg, Se, and Cu.
Outcomes Measured
- Requires manual extraction
Population
| Field | Value |
|---|---|
| Population | multiple sclerosis |
| Sample Size | 1567 |
| Age Range | See abstract |
| Condition | See abstract |
MeSH Terms
- Copper
- Humans
- Multiple Sclerosis
- Selenium
- Trace Elements
- Zinc
Evidence Classification
- Level: Meta Analysis
- Publication Types: Journal Article, Meta-Analysis, Systematic Review
- Vertical: magnesium
Provenance
- PMID: 33611740
- DOI: 10.1007/s12011-021-02621-5
- PMCID: Not in PMC
- Verified: 2026-04-09 via PubMed E-utilities API
Source extracted via PubMed E-utilities API on 2026-04-09